Tm. Vallis et Gk. Turnbull, IMPACT OF DISEASE-ACTIVITY ON THE QUALITY-OF-LIFE OF CROHNS-DISEASE PATIENTS, Canadian journal of gastroenterology, 10(5), 1996, pp. 310-315
Crohn's disease (CD) patients often suffer severe symptoms that impair
their quality of life. A sample of 39 CD patients who were assessed u
sing well validated measures of disease activity and disease-specific
quality of life is reported. Twenty-six of these patients were reasses
sed an average of four months after the initial assessment to determin
e the impact of changes in disease activity on quality of life. For th
e total sample (n=39) disease activity did not predict quality of life
for any of the scales of the Inflammatory Bower Disease Questionnaire
(IBDQ) (r<0.13 for each), Thus, examining fluctuations in disease act
ivity between patients did not demonstrate a disease activity quality
of life relationship. In contrast, changes in disease activity within
the same individuals over time (the repeat assessment sample, n=26) we
re correlated with changes in quality of life; increases in disease ac
tivity predicted decreases in quality of life on the IBDQ bowel sympto
ms subscale (r=-0.463, P<0.01) and the IBDQ systemic symptoms subscale
(r=0.44, P<0.05). The 10 patients with the largest decrease in diseas
e activity over time (mean decrease of 43.54 points using the Dutch Ac
tivity Index) had significant improvement in quality of life on the bo
wel and systemic subscales. In contrast, the nine patients with the la
rgest increase in disease activity over time (mean increase of 20.57 p
oints using the Dutch Activity Index) had significant reduction in qua
lity of life an the boa el and systemic symptoms subscales. These diff
erences between extreme groups were significant for both the bowel sym
ptoms (P<0.05) and systemic symptoms (P<0.05) subscales. The authors c
onclude that changes in disease activity affect some important aspects
of quality of life: aspects related to disease specific (bowel sympto
ms) and nondisease-specific (systemic symptoms) physical symptoms. Imp
ortantly, disease activity was not able to predict the emotional and s
ocial aspects of IBD-related quality of life. This suggests that nondi
sease factors need to be considered when working with CD patients. Fut
ure research should evaluate the role of psychological intervention in
improving quality of life for patients with reduced well-being, parti
cularly in areas of emotional and social functioning.